|
|
|
|
Active Indication- |
|
Drug Highest PhasePhase 1 |
First Approval Ctry. / Loc.US |
First Approval Date24 May 1984 |
[Translation] Study on the pharmacokinetics of cefuroxime for injection in healthy subjects
拟在健康受试者中进行注射用头孢雷特单次和多次给药人体药动学研究。评价健康受试者单次和多次静脉输注注射用头孢雷特的耐受性及安全性,计算主要药动学参数,评价单次和多次静脉输注注射用头孢雷特后受试者体内的药动学特征;同时考察尿药排泄情况。
[Translation] It is planned to conduct a single and multiple dose human pharmacokinetic study of Cefuroxime for Injection in healthy subjects. The tolerability and safety of single and multiple intravenous infusions of Cefuroxime for Injection in healthy subjects will be evaluated, the main pharmacokinetic parameters will be calculated, and the pharmacokinetic characteristics of Cefuroxime for Injection in subjects after single and multiple intravenous infusions will be evaluated; at the same time, the urinary excretion of the drug will be investigated.
100 Clinical Results associated with Jiangsu Sinoya Biomedical Technology Co., Ltd.
0 Patents (Medical) associated with Jiangsu Sinoya Biomedical Technology Co., Ltd.
100 Deals associated with Jiangsu Sinoya Biomedical Technology Co., Ltd.
100 Translational Medicine associated with Jiangsu Sinoya Biomedical Technology Co., Ltd.